Statement
The JPMA’s statements are posted here.
- July 9, 2026: On Institutional Reforms to Ensure a Stable Supply of Medicines and Other Products Necessary for Infectious Disease Control and to Promote the Development of New Antimicrobial Drugs
- June 27, 2025: Survey Report on the Issue of Antimicrobial-Resistant Bacteria
- November 11, 2024: Proposals from the Pharmaceutical Industry Regarding the Introduction of a Pull-Type Incentive System in the Antimicrobial Market
- May 9, 2024: Request for Measures to Promote Research and Development of Treatments for Priority Infectious Diseases (Including AMR)
- September 26, 2016: Initiatives to Improve Access to Medicines in Developing Countries
- August 2, 2016: Statement on the Streamlined Review Process for New Drugs in Taiwan
- July 26, 2016: JPMA recommendations for G7 Health Minister's Meeting:
- April 19, 2016: G7 Ise-Shima Summit:
